Current status and perspectives in immunotherapy for metastatic melanoma

Metastatic melanoma was the first malignancy in which immune checkpoint inhibitors demonstrated their successful efficacy. Currently, the knowledge on the interaction between the immune system and malignant disease is steadily increasing and new drugs and therapeutic strategies are overlooking in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Marconcini, Riccardo, Spagnolo, Francesco, Stucci, Luigia Stefania, Ribero, Simone, Marra, Elena, Rosa, Francesco De, Picasso, Virginia, Di Guardo, Lorenza, Cimminiello, Carolina, Cavalieri, Stefano, Orgiano, Laura, Tanda, Enrica, Spano, Laura, Falcone, Alfredo, Queirolo, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844761/
https://www.ncbi.nlm.nih.gov/pubmed/29552325
http://dx.doi.org/10.18632/oncotarget.23746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844761/
https://www.ncbi.nlm.nih.gov/pubmed/29552325
http://dx.doi.org/10.18632/oncotarget.23746

Ejemplares similares